L-Amino acids, when administered intra-peritoneally either individually or as mixtures to fasted rats, blocked the epinephrine-induced hyperglycemic response. The injection of 2.5 mmoles/kg of either arginine, lysine, leucine, isoleucine, threonine, or tryptophan inhibited epinephrine-induced hyperglycemia 76–89%. The same dosage of methionine or valine had less effect on the hyperglycemic response (42 and 32% respectively). By contrast phenylalanine and histidine did not exhibit significant inhibitory actions (4 and 6% respectively) at the same dosages. Equivalent amounts of bovine serum albumin, casein hydrolysate, or a mixture of 10 essential amino acids were no more inhibitory than either valine or methionine alone. In addition the non-metabolizable amino acids, α-aminoisobutyric acid and 1-aminocyclo-pentanecarboxylic acid are about as potent as methionine and valine in blocking epinephrine hyperglycemia. Several metabolites of tryptophan, namely indole-3-acetic acid, quinolinic acid, and hydroxyanthranilic acid blocked epinephrine hyperglycemia 87–99%. Xanthurenic acid, kynurenic acid, and serotonin inhibit the response 48–65%. DL-Kynurenine was the least potent exhibiting a 24-percent inhibition. In addition the tryptophan analogue, DL-α-methyltryptophan produced an 47-percent inhibition. The fact that no correlation could be found between the capacities of the amino acids to produce hypoglycemia and their capacity to inhibit epinephrine-induced hyperglycemia suggests than insulin is not involved in preventing the hyperglycemic response. This idea is supported by the observation that tryptophan inhibits epinephrine-induced hyperglycemia to the same extent in both intact and diabetic rats.

Keywords:
Amino acid, Epinephrine, Hyperglycemia, Essential amino acids, Tryptophan metabolites, Indole-3-acetic acid, Quinolinic acid, 3-Hydroxyanthranilic acid, Xanthurenic acid Kynurenic acid, Serotonin
This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.